About Cabling Installation & Maintenance

Our mission: Bringing practical business and technical intelligence to today's structured cabling professionals

For more than 30 years, Cabling Installation & Maintenance has provided useful, practical information to professionals responsible for the specification, design, installation and management of structured cabling systems serving enterprise, data center and other environments. These professionals are challenged to stay informed of constantly evolving standards, system-design and installation approaches, product and system capabilities, technologies, as well as applications that rely on high-performance structured cabling systems. Our editors synthesize these complex issues into multiple information products. This portfolio of information products provides concrete detail that improves the efficiency of day-to-day operations, and equips cabling professionals with the perspective that enables strategic planning for networks’ optimum long-term performance.

Throughout our annual magazine, weekly email newsletters and 24/7/365 website, Cabling Installation & Maintenance digs into the essential topics our audience focuses on.

  • Design, Installation and Testing: We explain the bottom-up design of cabling systems, from case histories of actual projects to solutions for specific problems or aspects of the design process. We also look at specific installations using a case-history approach to highlight challenging problems, solutions and unique features. Additionally, we examine evolving test-and-measurement technologies and techniques designed to address the standards-governed and practical-use performance requirements of cabling systems.
  • Technology: We evaluate product innovations and technology trends as they impact a particular product class through interviews with manufacturers, installers and users, as well as contributed articles from subject-matter experts.
  • Data Center: Cabling Installation & Maintenance takes an in-depth look at design and installation workmanship issues as well as the unique technology being deployed specifically for data centers.
  • Physical Security: Focusing on the areas in which security and IT—and the infrastructure for both—interlock and overlap, we pay specific attention to Internet Protocol’s influence over the development of security applications.
  • Standards: Tracking the activities of North American and international standards-making organizations, we provide updates on specifications that are in-progress, looking forward to how they will affect cabling-system design and installation. We also produce articles explaining the practical aspects of designing and installing cabling systems in accordance with the specifications of established standards.

Cabling Installation & Maintenance is published by Endeavor Business Media, a division of EndeavorB2B.

Contact Cabling Installation & Maintenance

Editorial

Patrick McLaughlin

Serena Aburahma

Advertising and Sponsorship Sales

Peter Fretty - Vice President, Market Leader

Tim Carli - Business Development Manager

Brayden Hudspeth - Sales Development Representative

Subscriptions and Memberships

Subscribe to our newsletters and manage your subscriptions

Feedback/Problems

Send a message to our general in-box

 

Biotech Community Curetopia Raises $1.77M to Advance Rare Disease Cures with Blockchain

By: Zexprwire

Curetopia, a Biotech DAO, leverages decentralized science to accelerate rare disease research

Zug, Switzerland, 20th March 2025, ZEX PR WIREIn a groundbreaking achievement, Curetopia, the first Biotech Decentralized Autonomous Organization (DAO) built natively on the Solana blockchain, raised $1.77 million last week to scale up drug repurposing for inherited metabolic diseases through the Bio Protocol Launchpad. This milestone is driving cutting-edge research aimed at developing the first treatment for AARS2 Deficiency, a potentially fatal rare genetic disease with no approved therapies currently on the market.

Curetopia’s innovative approach empowers patients and researchers to crowdfund medical breakthroughs, emphasizing community involvement and a shared stake in the resulting advancements. Over 1,000 individual contributors participated in this $1.77 million raise, highlighting the power of community-driven science. Participants in Curetopia’s decentralized clinical trials become active stakeholders in the therapies they help to develop.

A key outcome of this effort is the identification of two drug repurposing candidates for AARS2 Deficiency, uncovered by a fully de-risked, high-throughput, yeast-powered screening process. Curetopia is filing a provisional patent for this discovery, working with two pioneer AARS2 families on launching parallel N-of-1 studies, and plans to reinvest any future proceeds into further research initiatives.

Dr. Ethan Perlstein, founder and CEO of Curetopia, stated:

“The success of Curetopia’s auction in the face of brutal market conditions speaks to the fact that rare disease communities and crypto communities are natural allies. We’ve already demonstrated with the inaugural AARS2 program that we can deliver results on a timeline and with capital efficiency that is unheard of in TradBio. Now it’s time to cook.”

Curetopia is part of the growing Decentralized Science (DeSci) movement, which has collectively raised over $15 million for research in the past three months. This influx of funding is timely, as traditional sources like the NIH and NSF face ongoing budget pressures.

Moving forward, Curetopia will develop an AI-driven, decentralized clinical trial model to address thousands of rare diseases—each representing a $150 million market opportunity based on historical sales of Priority Review Vouchers. By focusing on drug repurposing, the organization seeks to expedite regulatory processes and deliver life-changing treatments to patients more quickly.

About Curetopia

Curetopia is a non-profit association pioneering the world’s first Biotech DAO dedicated to eradicating rare diseases through decentralized science launched via the Bio Protocol launchpad. With over 10,000 rare diseases affecting 1 in 10 people worldwide, Curetopia provides patient communities with innovative tools to fund research, drive innovation, and ensure promising therapies are not abandoned.

Bio Protocol is a new financial layer for early-stage biotech, accelerating the commercialization of breakthrough research. It enables global communities—patients, researchers, and crypto users—to fund and co-own biotech innovations from day one. Backed by Binance Labs, Northpond Ventures, and 1kx, Bio has facilitated over $50M in research funding worldwide.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.